QS21 [clinicaltrials_resource:d38bb59675fe6db9e190ee78739d20a9]
Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease [clinicaltrials:NCT00003357]Vaccine Therapy Plus Immune Adjuvants in Treating Patients With Advanced Melanoma [clinicaltrials:NCT00003362]Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00004052]Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy [clinicaltrials:NCT00004249]Vaccine Therapy in Treating Patients With Primary Stage II Melanoma [clinicaltrials:NCT00005052]Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00006041]Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer [clinicaltrials:NCT00006387]
intervention [clinicaltrials_vocabulary:intervention]
QS21 [clinicaltrials_resource:d38bb59675fe6db9e190ee78739d20a9]
Bio2RDF identifier
d38bb59675fe6db9e190ee78739d20a9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d38bb59675fe6db9e190ee78739d20a9
intervention name [clinicaltrials_vocabulary:intervention-name]
identifier
clinicaltrials_resource:d38bb59675fe6db9e190ee78739d20a9
title
QS21
@en
type
label
QS21 [clinicaltrials_resource:d38bb59675fe6db9e190ee78739d20a9]
@en